Maggie Fick

Skip to main content

Author

Thomson Reuters

72 results

Healthcare & PharmaceuticalscategoryEU, Pfizer/BioNTech announce amendment to COVID vaccine contractMay 26, 2023
BusinesscategoryAstraZeneca to leave leading U.S. drug lobby groupMay 16, 2023
BusinesscategoryEU needs tiered drug pricing to improve patient access, Bayer exec saysMay 5, 2023
BusinesscategoryNovo Nordisk: U.S. is priority for weight-loss drug over new marketsMay 4, 2023
BusinesscategoryInvestors see big Novo Nordisk stock boost if obesity drug shows heart benefitMay 3, 2023
Future of HealthcategoryPfizer pledge for more equal access to RSV shot faces hurdlesApril 29, 2023
Healthcare & PharmaceuticalscategoryEU publishes proposed drug laws overhaul, setting up tussle with industryApril 27, 2023
BusinesscategoryAstraZeneca beats estimates on strong emerging market sales as COVID wanesApril 27, 2023
BusinesscategoryAstraZeneca increases bets on China as COVID vaccine sales fadeApril 27, 2023
Future of HealthcategoryExplainer: After COVID and drug shortages, EU revamps drug lawsApril 26, 2023
BusinesscategoryGSK stays strong as healthy sales beat expectationsApril 26, 2023
BusinesscategoryGSK says EU pharma legislation overhaul could trigger investment shiftApril 26, 2023
Healthcare & PharmaceuticalscategoryAstraZeneca confident new COVID antibody protects against known variantsApril 18, 2023
BusinesscategoryCOVID led to sharp rise in vaccine compensation schemes, but gaps remain -OxfordMarch 30, 2023
Healthcare & PharmaceuticalscategoryGSK licenses companies to make cheap copies of HIV prevention drugMarch 30, 2023
Healthcare & PharmaceuticalscategoryGSK sees $500 mln peak sales for yeast infection pill licensed from ScynexisMarch 30, 2023
LegalcategoryGSK loses bid to keep experts out of upcoming Zantac trialMarch 24, 2023
Healthcare & PharmaceuticalscategoryHow GSK plans to replenish its depleted medicine cabinetMarch 15, 2023
WorldcategorySVB shock could have chilling effect on British biotech sectorMarch 13, 2023
Future of HealthcategoryPfizer ready to launch RSV vaccines for older adults, pregnant women in US, EuropeMarch 9, 2023

1 to 20 of 72